T. Rowe Price Investment Management’s Elanco Animal Health ELAN Stock Holding History

T. Rowe Price Investment Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$708M	Sell	28,750,719 -5,884,367	-17%	-$136M	0.46%	48
2026 Q1	$829M	Sell	34,635,086 -592,332	-2%	-$14.5M	0.57%	39
2025 Q4	$797M	Buy	35,227,418 +3,717,404	+12%	+$80.9M	0.5%	50
2025 Q3	$635M	Buy	31,510,014 +11,955,072	+61%	+$200M	0.39%	65
2025 Q2	$279M	Buy	19,554,942 +3,571,551	+22%	+$41.7M	0.18%	139
2025 Q1	$168M	Buy	15,983,391 +292,655	+2%	+$3.31M	0.11%	194
2024 Q4	$190M	Sell	15,690,736 -5,352,070	-25%	-$70M	0.12%	186
2024 Q3	$309M	Buy	21,042,806 +11,272,346	+115%	+$157M	0.19%	130
2024 Q2	$141M	Buy	9,770,460 +421,847	+5%	+$6.74M	0.09%	226
2024 Q1	$152M	Buy	9,348,613 +3,516,125	+60%	+$55M	0.09%	225
2023 Q4	$86.9M	Buy	5,832,488 +3,522,982	+153%	+$39.9M	0.06%	295
2023 Q3	$26M	Buy	+2,309,506	New	+$26.8M	0.02%	453

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

T. Rowe Price Investment Management's ELAN Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Elanco Animal Health (ELAN) stake by 17% in Q2 2026, selling an estimated $136M and leaving 28,750,719 shares worth $708M. The position accounts for 0.46% of the portfolio, ranked #48.

T. Rowe Price Investment Management first reported a position in ELAN in Q3 2023 and has held it in 12 quarters since. The position peaked at $829M in Q1 2026. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

T. Rowe Price Investment Management held 28,750,719 shares of Elanco Animal Health worth $708M as of Q2 2026.
T. Rowe Price Investment Management sold 5,884,367 Elanco Animal Health shares in Q2 2026, an estimated $136M.
Elanco Animal Health made up 0.46% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #48 holding.
T. Rowe Price Investment Management first reported a position in Elanco Animal Health in Q3 2023 and has held it in 12 quarters since.
T. Rowe Price Investment Management's Elanco Animal Health position peaked at $829M in Q1 2026.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.